Biomaterials their Place in Health Systems

Introduction

Biomaterials have a wide application in the medical field solving almost every challenge. One of the significant challenges faced by old people is a loss of smell. Through other, medical and non-medical conditions people can quickly develop these implications. There is limited research on the treatment mechanisms for people who have lost smell. While depending on the condition, some people are treated permanently there is an equal likelihood of losing the smell completely. There is a need for continuous research to increase the efficiency of the treatment method as well as develop new medical strategies to help these patients. Losing smell can be dangerous as one can be exposed to hazardous gas materials. Not detecting a gas leak can be equally dangerous and can lead the patient to be in challenging conditions. There is also the likelihood that one would be exposed to depression and there is a loss of appetite.

According to Langer, R., and Tirrell, (2004) Biomaterials have had an established position in the healthcare systems. The application can include prosthetic and drug delivery substances. Drug delivery systems are the main focus of this research. The treatment methods for smell problems are highly limited. Nasal decongestants have a full application in the medical field and surgery is also a conventional treatment method to remove the nasal polyps. There is yet a more productive application of the biomaterials to be established through research to define and increase efficiency in the treatment of the smelling problem. In the case of anosmia the patient is unable to detect anything thoroughly. The focus of this research is on the use of the biomaterials in the treatment of nasal polyps considered as a significant cause of challenges in the treatment problems. Most often after surgery patients will encounter more difficulties and hence the use of biomaterials likes the nasal packing, and the sinus stents could be useful (Santarelli, & Han, 2016). Biomaterials can offer efficient services to the patients with smelling difficulties especially those caused by nasal polyps since most of the patients and health practitioners fear that such an application could intensify based on association with problems of Chronic rhinosinusitis (CRS).

Problem Statement

The main problem is the determination of biomaterials effectiveness in smelling problems associated with nasal polyps. The main problem of focus smells problems that are directly associated with nasal polyps swellings. Chronic rhinosinusitis is a critical challenge that is often associated with the nasal polyps. The nasal polyps cause smelling difficulties to patients, and therefore treatment of nasal polyps needs very sensitive medical systems that will improve the patient's welfare without causing more problems. The nasal polyps can be subjected to surgery since the inflammations are non-cancerous and hence in return exposing the organs into more grave dangers. By use of the biomaterials, the patient's outcome will be significantly improved, and the level of implications will be controlled. The physicians will, however, have a responsibility in determining the effectiveness and the procedures of using the biomaterials in the delivery of services. 

The biomaterials can be used for both implants and also in the drug delivery systems following the operations. To use the materials developed and designed by this research the preference of the patients will be put into considerations by the physicians delivering such services. Nasal polyps pose critical situations since they can grow back following treatment such as surgery. Chronic sinusitis is caused by bacteria and fungal infections which are associated with the presence of microfilms that overcome the interventions of the antibiotics. The physicians often avoid surgery treatment since the nasal polyps have that critical tendency to grow back and such the patients may continually develop more implications. With the medical treatment methods also the use of biomaterials would be significantly recommended although their application would be limited and isn't a significant concern of the treatment method.

Implant Design Section

The implant is to be made of well cross-linked mesh-like materials that will enhance adsorbent of the drugs onto the surface of the biomaterials. The materials used for this design is carboxymethyl cellulose (CMC) which has the potential to improve hydration and dissolving the materials. The material is flexible such that it will be highly optimized to enhance quick and reliable penetration through the nasal cavity. Technically the materials will be used for delivering the drugs to heal the wounds after the surgery. Most of such operations are limited to the specifications of the physicians. Several models will be designed for physicians to recommend based on the condition of individual patients. This approach is both reliable and dependable in the delivery of substances.

 Several polymers can be fitted to ensure efficiency for the overall design. The considerations to be made will include materials like bioresorbable gel stent which are a primary tool for adsorption and are made of hyaluronic acid. The material is not only flexible but also gives the drugs a highly efficient adsorbent material. Most of the medications recommended for treatment of nasal polyps both before and after surgery would require biomaterials with efficient adsorption and flexibility to penetrate through the nasal cavity. This is even more sensitive when the materials to be delivered to the nasal cavity are relied on after conducting the surgery. One consideration is that when the material hydrates the biopolymers will transform into a mucoadhesive gel that is critical for this operation. The stents or the implants can be placed on the cavity to also help in the relieve of pain on the after the patients after the surgery.

Analysis of the Topic

Using the biomaterials for the delivery of drugs after nasal polyps operations would be considered critical to the achievement of these research objectives. The emphasis is placed on an improvement of the overall patients' outcome without interference with other possible medical conditions. The presence of the microfilm on the bacteria which leads to an increased need for intervention by physicians will be utilized for these materials. Most often the physicians have difficulties in the treatment of patients who have challenges smelling since the treatment methods available could either be less effective or would the patients in more dangers. Considering the age most of the patients need well-coordinated interventions that consider the elimination of the nasal polyps, coating the surfaces and delivering the drug substance effectively without causing pain to the patients. Two characteristics of the materials are critical, the absorbance and the flexibility which the elements need to fulfill.

Highlights Recent Researches

The most recent studies are that confirms that biomaterials can be used in the treatment of nasal cavity implications through packing and the sinus stents and especially in the treatment of patients with other infections like chronic rhinosinusitis. The research also affirms that the use of biomaterials in the treatment of the nasal difficulties is a consideration for both the patient and the surgeon. In case the action would lead to increased problems to the patient such a patient would instead be subjected to less efficient operations. However although not fully implemented in the healthcare systems the recommendations highlighted for through packing and stents are being considered as highly effective.

Conclusion

The research for this study affirms that biomaterials have a wide application in the healthcare system. The research identifies a well-integrated design of the biomaterials to ensure they are flexible enough to penetrate the cavity even after the operations. The material needs to have high absorbance to hold a wide range of drugs that are used for the treatment of various infections associated with nasal polyps. In other words, the research builds on the current study to outline how varieties of recommendations could be integrated to give more reliable outcomes for the patient and a clear guideline to the physicians.  

Cite this page